Invivo hepatocyte MR imaging using lactose functionalized magnetoliposomes

Biomaterials

Volumn 35, Issue 3, 2014, Pages 1015-1024

  Ketkar Atre, Ashwini ^a   Struys, Tom ^a,b   Dresselaers, Tom ^a   Hodenius, Michael ^a,c   Mannaerts, Inge ^d   Ni, Yicheng ^a   Lambrichts, Ivo ^b   Van Grunsven, Leo A ^d   De Cuyper, Marcel ^c   Himmelreich, Uwe ^a  

^a DEPARTMENT OF IMAGING AND PATHOLOGY   (Belgium)

^b HASSELT UNIVERSITY   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Asialoglycoprotein receptor (ASGPr 1); Hepatocyte; Lactose; Liver; Magnetoliposomes; MRI

Indexed keywords

ASIALOGLYCOPROTEIN RECEPTORS; CONTRAST ENHANCEMENT; HEPATIC STELLATE CELLS; HEPATOCYTE TARGETING; HEPATOCYTES; INTRAVENOUS ADMINISTRATION; LACTOSE; MAGNETOLIPOSOMES;

ANIMALS; DIAGNOSIS; DYNAMIC LIGHT SCATTERING; LIVER; MAGNETIC RESONANCE IMAGING; SIGNAL SYSTEMS; TRANSMISSION ELECTRON MICROSCOPY;

SUGARS;

ASIALOGLYCOPROTEIN RECEPTOR; FERRIC FERROCYANIDE; IRON OXIDE; LACTOSE; LIPOSOME; MAGNETOLIPOSOME; UNCLASSIFIED DRUG; ANION; CONTRAST MEDIUM; DIAGNOSTIC AGENT; FERRIC ION; FERRIC OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL FRACTIONATION; CELL SPECIFICITY; CELLULAR DISTRIBUTION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG UPTAKE; EX VIVO STUDY; HISTOLOGY; HYDRODYNAMICS; IMAGE ANALYSIS; IMAGE PROCESSING; IN VIVO STUDY; KUPFFER CELL; LIGHT SCATTERING; LIVER CELL; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STELLATE CELL; TRANSMISSION ELECTRON MICROSCOPY; WHOLE BODY MRI; ANIMAL; ASIALOGLYCOPROTEIN RECEPTOR (ASGPR-1); CELL CULTURE; CHEMISTRY; CYTOLOGY; LIVER; LIVER DISEASE; MAGNETOLIPOSOMES; METHODOLOGY; PATHOLOGY; ULTRASTRUCTURE;

ANIMALIA;

ASIALOGLYCOPROTEIN RECEPTOR (ASGPR-1); HEPATOCYTE; LACTOSE; LIVER; MAGNETOLIPOSOMES; MRI;

ANIMALS; ANIONS; ASIALOGLYCOPROTEIN RECEPTOR; CELLS, CULTURED; CONTRAST MEDIA; FERRIC COMPOUNDS; HEPATOCYTES; LACTOSE; LIPOSOMES; LIVER; LIVER DISEASES; MAGNETIC RESONANCE IMAGING; MALE; MICE;

EID: 84887619630     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.10.029     Document Type: Article

References (34)

1. Manning D.S., Afdhal N.H. Diagnosis and quantitation of fibrosis. Gastroenterology 2008, 134:1670-1681.
2. Castera L. Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterology 2012, 142:1293-1302.
3. Clasen S., Boss A., Schmidt D., Fritz J., Schraml C., Claussen C.D., et al. Magnetic resonance imaging for hepatic radiofrequency ablation. Eur J Radiol 2006, 59:140-148.
4. Kanematsu M., Goshima S., Watanabe H., Kondo H., Kawada H., Noda Y., et al. Detection and characterization of focal hepatic lesions with diffusion-weighted MR imaging: a pictorial review. Abdom Imaging 2013, 38:297-308.
5. Koike N., Cho A., Nasu K., Seto K., Nagaya S., Ohshima Y., et al. Role of diffusion-weighted magnetic resonance imaging in the differential diagnosis of focal hepatic lesions. World J Gastroenterol 2009, 15:5805-5812.
6. Bellin M.F. MR contrast agents, the old and the new. Eur J Radiol 2006, 60:314-323.
7. Gupta S., Rajvanshi P., Lee C.D. Integration of transplanted hepatocytes into host liver plates demonstrated with dipeptidyl peptidase IV-deficient rats. Proc Natl Acad Sci U S A 1995, 92:5860-5864.
8. Karabulut N., Elmas N. Contrast agents used in MR imaging of the liver. Diagn Interv Radiol 2006, 12:22-30.
9. Morana G., Salviato E., Guarise A. Contrast agents for hepatic MRI. Cancer Imaging 2007, 7(A):S24-S27.
10. Puppi J., Modo M. Use of magnetic resonance imaging contrast agents to detect transplanted liver cells. Top Magn Reson Imaging 2009, 20:113-120.
11. Bellin M.F., Vasile M., Morel-Precetti S. Currently used non-specific extracellular MR contrast media. Eur Radiol 2003, 13:2688-2698.
12. Seneterre E., Weissleder R., Jaramillo D., Reimer P., Lee A.S., Brady T.J., et al. Bone marrow: ultrasmall superparamagnetic iron oxide for MR imaging. Radiology 1991, 179:529-533.
13. Weissleder R., Elizondo G., Wittenberg J., Lee A.S., Josephson L., Brady T.J. Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology 1990, 175:494-498.
14. Gandhi S.N., Brown M.A., Wong J.G., Aguirre D.A., Sirlin C.B. MR contrast agents for liver imaging: what, when, how. Radiographics 2006, 26:1621-1636.
15. Tanimoto A., Kuribayashi S. Hepatocyte-targeted MR contrast agents: contrast enhanced detection of liver cancer in diffusely damaged liver. Magn Reson Med Sci 2005, 4:53-60.
16. Kim E.M., Jeong H.J., Park I.K., Cho C.S., Kim C.G., Bom H.S. Hepatocyte-targeted nuclear imaging using 99mTc-galactosylated chitosan: conjugation, targeting, and biodistribution. JNucl Med 2005, 46:141-145.
17. Kim E.M., Jeong H.J., Park I.K., Cho C.S., Moon H.B., Yu D.Y., et al. Asialoglycoprotein receptor targeted gene delivery using galactosylated polyethylenimine-graft-poly(ethylene glycol): invitro and invivo studies. JControl Release 2005, 108:557-567.
18. Stockert R.J. The asialoglycoprotein receptor: relationships between structure, function, and expression. Physiol Rev 1995, 75:591-609.
19. Pricer W.E., Ashwell G. The binding of desialylated glycoproteins by plasma membranes of rat liver. JBiol Chem 1971, 246:4825-4833.
20. Kamruzzaman Selim K.M., Ha Y.S., Kim S.J., Chang Y., Kim T.J., Ho Lee G., et al. Surface modification of magnetite nanoparticles using lactobionic acid and their interaction with hepatocytes. Biomaterials 2007, 28:710-716.
21. Yoo M.K., Kim I.Y., Kim E.M., Jeong H.J., Lee C.M., Jeong Y.Y., et al. Superparamagnetic iron oxide nanoparticles coated with galactose-carrying polymer for hepatocyte targeting. JBiomed Biotechnol 2007, 2007:94740.
22. Huang G., Diakur J., Xu Z., Wiebe L.I. Asialoglycoprotein receptor-targeted superparamagnetic iron oxide nanoparticles. Int J Pharm 2008, 360:197-203.
23. Wu D.Q., Lu B., Chang C., Chen C.S., Wang T., Zhang Y.Y., et al. Galactosylated fluorescent labeled micelles as a liver targeting drug carrier. Biomaterials 2009, 30:1363-1371.
24. Lee C.M., Jeong H.J., Kim S.L., Kim E.M., Kim D.W., Lim S.T., et al. SPION-loaded chitosan-linoleic acid nanoparticles to target hepatocytes. Int J Pharm 2009, 371:163-169.
25. Cheong S.J., Lee C.M., Kim S.L., Jeong H.J., Kim E.M., Park E.H., et al. Superparamagnetic iron oxide nanoparticles-loaded chitosan-linoleic acid nanoparticles as an effective hepatocyte-targeted gene delivery system. Int J Pharm 2009, 372:169-176.
26. Soenen S.J., Brisson A.R., Jonckheere E., Nuytten N., Tan S., Himmelreich U., et al. The labeling of cationic iron oxide nanoparticle-resistant hepatocellular carcinoma cells using targeted magnetoliposomes. Biomaterials 2011, 32:1748-1758.
27. Soenen S., Vande Velde G., Ketkar-Atre A., Himmelreich U., De Cuyper M. Magnetoliposomes as MRI contrast agents. WIREs Nanomed Nanobiotechnol 2011, 3:197-211.
28. De Cuyper M., Joniau M. Magnetoliposomes. Formation and structural characterization. Eur Biophys J 1988, 15:311-319.
29. Dong L., Gao S., Diao H., Chen J., Zhang J. Galactosylated low molecular weight chitosan as a carrier delivering oligonucleotides to Kupffer cells instead of hepatocytes invivo. JBiomed Mater Res A 2008, 84:777-784.
30. Popielarski S.R., Pun S.H., Davis M.E. Ananoparticle-based model delivery system to guide the rational design of gene delivery to the liver. 1. Synthesis and characterization. Bioconjug Chem 2005, 16:1063-1070.
31. Rensen P.C., Sliedregt L.A., Ferns M., Kieviet E., van Rossenberg S.M., van Leeuwen S.H., et al. Determination of the upper size limit for uptake and processing of ligands by the asialoglycoprotein receptor on hepatocytes invitro and invivo. JBiol Chem 2001, 276:37577-37584.
32. Rieder H., Meyer zum Buschenfelde K.H., Ramadori G. Functional spectrum of sinusoidal endothelial liver cells. Filtration, endocytosis, synthetic capacities and intercellular communication. JHepatol 1992, 15:237-250.
33. Roca A.G., Veintemillas-Verdaguer S., Port M., Robic C., Serna C.J., Morales M.P. Effect of nanoparticle and aggregate size on the relaxometric properties of MR contrast agents based on high quality magnetite nanoparticles. JPhys Chem B 2009, 113:7033-7039.
34. Sancho-Bru P., Najimi M., Caruso M., Pauwelyn K., Cantz T., Forbes S., et al. Stem and progenitor cells for liver repopulation: can we standardise the process from bench to bedside?. Gut 2009, 58:594-603.